Hazard rate of tumor recurrence over time: A pooled-analysis of three clinical trials with fluoropyrimidine-based adjuvant chemotherapy for colorectal cancer achieved by the Japanese foundation for multidisciplinary treatment of cancer (JFMC)

Hiromichi Maeda; Koji Oba; Chikuma Hamada; Sotaro Sadahiro; Toru Aoyama; Michitaka Honda; Shuhei Mayanagi; Kosuke Kashiwabara; Junichi Sakamoto; Shigetoyo Saji; Takaki Yoshikawa

doi:10.4993/acrt.24.60

Hazard rate of tumor recurrence over time: A pooled-analysis of three clinical trials with fluoropyrimidine-based adjuvant chemotherapy for colorectal cancer achieved by the Japanese foundation for multidisciplinary treatment of cancer (JFMC)

Hiromichi Maeda, Koji Oba, Chikuma Hamada, Sotaro Sadahiro, Toru Aoyama, Michitaka Honda, Shuhei Mayanagi, Kosuke Kashiwabara, Junichi Sakamoto, Shigetoyo Saji, Takaki Yoshikawa

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Estimation of the risk for tumor recurrence after curative resection of colorectal cancer is essential for establishment of a treatment plan and surveillance schedule. Several studies have identified the risk factors for the tumor recurrence occurring within a specific period of time, but the knowledge concerning the transition of the hazard rate over time and the effect of clinical variables on it is scarce. Herein, we would like to introduce the concept of the present study with summarized methods, and to report the fixation of the data and completion of the analysis.

Original language	English
Pages (from-to)	60-61
Number of pages	2
Journal	Annals of Cancer Research and Therapy
Volume	24
Issue number	2
DOIs	https://doi.org/10.4993/acrt.24.60
Publication status	Published - 2016
Externally published	Yes

Keywords

DFS
Early
Hazard rate
Late
Surveillance
UFT

ASJC Scopus subject areas

Oncology
Cancer Research
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4993/acrt.24.60

Fingerprint

Dive into the research topics of 'Hazard rate of tumor recurrence over time: A pooled-analysis of three clinical trials with fluoropyrimidine-based adjuvant chemotherapy for colorectal cancer achieved by the Japanese foundation for multidisciplinary treatment of cancer (JFMC)'. Together they form a unique fingerprint.

Cite this

Maeda, H., Oba, K., Hamada, C., Sadahiro, S., Aoyama, T., Honda, M., Mayanagi, S., Kashiwabara, K., Sakamoto, J., Saji, S., & Yoshikawa, T. (2016). Hazard rate of tumor recurrence over time: A pooled-analysis of three clinical trials with fluoropyrimidine-based adjuvant chemotherapy for colorectal cancer achieved by the Japanese foundation for multidisciplinary treatment of cancer (JFMC). Annals of Cancer Research and Therapy, 24(2), 60-61. https://doi.org/10.4993/acrt.24.60

Hazard rate of tumor recurrence over time : A pooled-analysis of three clinical trials with fluoropyrimidine-based adjuvant chemotherapy for colorectal cancer achieved by the Japanese foundation for multidisciplinary treatment of cancer (JFMC). / Maeda, Hiromichi; Oba, Koji; Hamada, Chikuma et al.

In: Annals of Cancer Research and Therapy, Vol. 24, No. 2, 2016, p. 60-61.

Research output: Contribution to journal › Article › peer-review

Maeda, H, Oba, K, Hamada, C, Sadahiro, S, Aoyama, T, Honda, M, Mayanagi, S, Kashiwabara, K, Sakamoto, J, Saji, S & Yoshikawa, T 2016, 'Hazard rate of tumor recurrence over time: A pooled-analysis of three clinical trials with fluoropyrimidine-based adjuvant chemotherapy for colorectal cancer achieved by the Japanese foundation for multidisciplinary treatment of cancer (JFMC)', Annals of Cancer Research and Therapy, vol. 24, no. 2, pp. 60-61. https://doi.org/10.4993/acrt.24.60

Maeda H, Oba K, Hamada C, Sadahiro S, Aoyama T, Honda M et al. Hazard rate of tumor recurrence over time: A pooled-analysis of three clinical trials with fluoropyrimidine-based adjuvant chemotherapy for colorectal cancer achieved by the Japanese foundation for multidisciplinary treatment of cancer (JFMC). Annals of Cancer Research and Therapy. 2016;24(2):60-61. doi: 10.4993/acrt.24.60

Maeda, Hiromichi ; Oba, Koji ; Hamada, Chikuma et al. / Hazard rate of tumor recurrence over time : A pooled-analysis of three clinical trials with fluoropyrimidine-based adjuvant chemotherapy for colorectal cancer achieved by the Japanese foundation for multidisciplinary treatment of cancer (JFMC). In: Annals of Cancer Research and Therapy. 2016 ; Vol. 24, No. 2. pp. 60-61.

@article{333cc5c58e7c46d988c9d190b8f4f0ed,

title = "Hazard rate of tumor recurrence over time: A pooled-analysis of three clinical trials with fluoropyrimidine-based adjuvant chemotherapy for colorectal cancer achieved by the Japanese foundation for multidisciplinary treatment of cancer (JFMC)",

abstract = "Estimation of the risk for tumor recurrence after curative resection of colorectal cancer is essential for establishment of a treatment plan and surveillance schedule. Several studies have identified the risk factors for the tumor recurrence occurring within a specific period of time, but the knowledge concerning the transition of the hazard rate over time and the effect of clinical variables on it is scarce. Herein, we would like to introduce the concept of the present study with summarized methods, and to report the fixation of the data and completion of the analysis.",

keywords = "DFS, Early, Hazard rate, Late, Surveillance, UFT",

author = "Hiromichi Maeda and Koji Oba and Chikuma Hamada and Sotaro Sadahiro and Toru Aoyama and Michitaka Honda and Shuhei Mayanagi and Kosuke Kashiwabara and Junichi Sakamoto and Shigetoyo Saji and Takaki Yoshikawa",

year = "2016",

doi = "10.4993/acrt.24.60",

language = "English",

volume = "24",

pages = "60--61",

journal = "Annals of Cancer Research and Therapy",

issn = "1344-6835",

publisher = "PJD Publications Ltd",

number = "2",

}

TY - JOUR

T1 - Hazard rate of tumor recurrence over time

T2 - A pooled-analysis of three clinical trials with fluoropyrimidine-based adjuvant chemotherapy for colorectal cancer achieved by the Japanese foundation for multidisciplinary treatment of cancer (JFMC)

AU - Maeda, Hiromichi

AU - Oba, Koji

AU - Hamada, Chikuma

AU - Sadahiro, Sotaro

AU - Aoyama, Toru

AU - Honda, Michitaka

AU - Mayanagi, Shuhei

AU - Kashiwabara, Kosuke

AU - Sakamoto, Junichi

AU - Saji, Shigetoyo

AU - Yoshikawa, Takaki

PY - 2016

Y1 - 2016

N2 - Estimation of the risk for tumor recurrence after curative resection of colorectal cancer is essential for establishment of a treatment plan and surveillance schedule. Several studies have identified the risk factors for the tumor recurrence occurring within a specific period of time, but the knowledge concerning the transition of the hazard rate over time and the effect of clinical variables on it is scarce. Herein, we would like to introduce the concept of the present study with summarized methods, and to report the fixation of the data and completion of the analysis.

AB - Estimation of the risk for tumor recurrence after curative resection of colorectal cancer is essential for establishment of a treatment plan and surveillance schedule. Several studies have identified the risk factors for the tumor recurrence occurring within a specific period of time, but the knowledge concerning the transition of the hazard rate over time and the effect of clinical variables on it is scarce. Herein, we would like to introduce the concept of the present study with summarized methods, and to report the fixation of the data and completion of the analysis.

KW - DFS

KW - Early

KW - Hazard rate

KW - Late

KW - Surveillance

KW - UFT

UR - http://www.scopus.com/inward/record.url?scp=85015323614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015323614&partnerID=8YFLogxK

U2 - 10.4993/acrt.24.60

DO - 10.4993/acrt.24.60

M3 - Article

AN - SCOPUS:85015323614

SN - 1344-6835

VL - 24

SP - 60

EP - 61

JO - Annals of Cancer Research and Therapy

JF - Annals of Cancer Research and Therapy

IS - 2

ER -

Hazard rate of tumor recurrence over time: A pooled-analysis of three clinical trials with fluoropyrimidine-based adjuvant chemotherapy for colorectal cancer achieved by the Japanese foundation for multidisciplinary treatment of cancer (JFMC)

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this